These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8312808)

  • 1. [The pharmacokinetic and pharmacodynamic characteristics of foridon during interaction with the metabolic oxidation inhibitor dopegit].
    Kukes VG; Alekhin SN; Rumiantsev AS; Gneushev ET; Gushchin AS; Germanov DV
    Eksp Klin Farmakol; 1993; 56(5):38-41. PubMed ID: 8312808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The clinical pharmacology and efficacy of the new Soviet calcium antagonist foridon].
    Kukes VG; Rumiantsev AS; Gneushev ET; Al'perovich BR; Svetyĭ LI; Nasyrov MN; Taratuta TV
    Ter Arkh; 1990; 62(10):138-42. PubMed ID: 2084878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hemodynamic mechanisms of the hypotensive action of the new calcium antagonist foridon in acute hypertension in rabbits. A comparison with nifedipine].
    Medvedev OS; Glukhovtsev EV; Dugin SF
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):44-9. PubMed ID: 3801131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of nifedipine in untreated and atorvastatin-treated hyperlipidemic rats.
    Eliot LA; Jamali F
    J Pharmacol Exp Ther; 1999 Oct; 291(1):188-93. PubMed ID: 10490903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Foridone and other calcium antagonists in the treatment of essential hypertension.
    Andreeva TN
    Cor Vasa; 1990; 32(1):45-55. PubMed ID: 2160361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetic and pharmacodynamic effects of isradipine in patients with arterial hypertension].
    Svetyĭ LI; Alekhin SN
    Eksp Klin Farmakol; 2002; 65(5):35-8. PubMed ID: 12596512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamics and exercise tolerance after bisoprolol, nifedipine, and their combination in patients with angina pectoris.
    Schnellbacher K; Bestehorn HP; Roskamm H
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S201-7. PubMed ID: 11527130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Principles of the pharmacokinetics and pharmacodynamics of calcium antagonists].
    Rameis H
    Wien Med Wochenschr; 1993; 143(19-20):490-500. PubMed ID: 8135031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose- and administration time-dependent effects of nifedipine gits on ambulatory blood pressure in hypertensive subjects.
    Hermida RC; Calvo C; Ayala DE; López JE; Rodríguez M; Chayán L; Mojón A; Fontao MJ; Fernández JR
    Chronobiol Int; 2007; 24(3):471-93. PubMed ID: 17612946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and pharmacodynamic differences between nifedipine capsule and GITS formulations in hypertensive patients.
    Isordia I; Carrasco M; Chávez-Negrete A; Palma-Aguirre JA; Flores-Murrieta FJ; Castañeda-Hernández G
    Int J Clin Pharmacol Ther; 1997 Mar; 35(3):133. PubMed ID: 9089004
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes in central and regional hemodynamics in patients with essential hypertension and the effect on hemodynamics of a course of treatment with dopegit].
    Leshchinskiĭ LA; Petrov NM; Pishchulina ES; Logacheva IV
    Ter Arkh; 1974; 46(10):104-13. PubMed ID: 4432212
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of barnidipine on blood pressure and serum metabolic parameters in patients with essential hypertension: a pilot study.
    Spirou A; Rizos E; Liberopoulos EN; Kolaitis N; Achimastos A; Tselepis AD; Elisaf M
    J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):256-61. PubMed ID: 17220472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The comparative effect of calcium antagonists on hemodynamics in patients with a stable form of essential hypertension (a randomized study)].
    Belousov IuB; Akhadov ShV; Volkov MG
    Ter Arkh; 1994; 66(3):72-7. PubMed ID: 8202859
    [No Abstract]   [Full Text] [Related]  

  • 15. Rosiglitazone has no clinically significant effect on nifedipine pharmacokinetics.
    Harris RZ; Inglis AM; Miller AK; Thompson KA; Finnerty D; Patterson S; Jorkasky DK; Freed MI
    J Clin Pharmacol; 1999 Nov; 39(11):1189-94. PubMed ID: 10579151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The comparative efficacy and prognosis of the long-term treatment with korinfar of men and women suffering from hypertension].
    Maslova NP; Baranova EI; Barabanova NG
    Ter Arkh; 1991; 63(8):52-5. PubMed ID: 1792619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A comparative clinico-pharmacological study of adalat, foridone, siskor, lomir effects on cerebral and peripheral circulation in patients with arterial hypertension].
    Svetyĭ LI; Alekhin SN; Pavlova LI; Kuchumov RS
    Klin Med (Mosk); 2002; 80(10):46-50. PubMed ID: 12471839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of nifedipine and nicardipine on regional cerebral blood flow distribution in patients with arterial hypertension.
    Akopov SE; Simonian NA; Kazarian AV
    Methods Find Exp Clin Pharmacol; 1996 Dec; 18(10):685-92. PubMed ID: 9121225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group.
    Zanchetti A
    Blood Press Suppl; 1995; 3():38-46. PubMed ID: 8535541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time course of regression of vascular structural changes and its relation to cytosolic free calcium in hypertensives after nilvadipine treatment.
    Ueno H; Takata M; Oh-hashi S; Tomoda F; Yasumoto K; Inoue H
    J Hum Hypertens; 1995 Sep; 9(9):735-9. PubMed ID: 8551487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.